GINOP Plusz 3.2.1-21 A munkavállalók és vállalatok alkalmazkodóképességének és termelékenységének javítása a munkaerő fejlesztésén keresztül A GINOP Plusz-3.2.1-21 pályázat keretében megvalósuló képzéseink célja, hogy munkatársaink naprakész tudással és fejlett...
After a successful ANVISA our company colleagues (dr. Beatrix Bostai and Mr. Viktor Fekete) attended FCE Pharma, in Sao Paolo, Brasil.Date: 2024 June...
We are proud to share that during this week (27 November, 2023 – 1 December, 2023) the Brazilian Health Regulatory Agency, ANVISA has successfully inspected our site located in Budapest, Hungary, yielding zero observations during the inspection. Thus we continue our...
On 2023 December 7th, CF Pharma hosted an event for KÖVET Association, titled “4th ESG Club”. Nearly 30 people took part. Although the guests came from various sectors of the economy – large pharmaceutical companies, banks, giant utility providers, small...
It fills us with pride that we earned the Family-friendly workplace certification. We help with part-time and atypical employment, as well as the employment of expectant mothers and pensioners. We support training, employee health protection, and summer supervision of...
Meat the EHS Heads and researchers of Hungarian Pharma Producers and hold a seminar on the topic of Process Safety. The experiments of the past years underlines how important is to know before the industrialization the reaction kinetic, thermal effects and possible...
If your are interested in the pharmaceutical industry and would like to work at a hungarian owned SME, then we’ve got you covered! Lets meet at the HVG Job fair! Date: 2023 October 4, 5, 6. Location: Budapest, Papp László...
Some functionality on this site requires your consent for cookies to work properly.
We use cookies to enhance your visit. By clicking Agree and Proceed you accept our use of cookies. You can also click on More Information to see detailed descriptions of the types of cookies and choose whether to accept certain cookies while on the site.